MedTrace Logo

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma

NCT07074756 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-03-27

No results posted yet for this study

Summary

This clinical trial tests how well a digital treatment platform using a mobile application works for the delivery of home-based sequential therapy in patients with glioma. Access to specialized neuro-oncology care in the United States for patients with glioma is critically deficient. Care at centers with neuro-oncology specialists is associated with improved survival outcomes, yet many patients have limited access due to distance, disease-related disability, or lack of financial resources. The application provides patients continuous access to their care team in the home setting. A digital treatment platform may increase clinical trial participation and accelerate development of novel therapeutics while addressing a great health disparity in patients with glioma.

Conditions

Interventions

DRUG

Chemotherapy

Receive standard of care chemotherapy

PROCEDURE

Computed Tomography

Undergo CT

OTHER

Internet-Based Intervention

Receive access to the remote chemotherapy management and patient monitoring platform

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Neurologic Examination

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

BEHAVIORAL

Surveillance

Undergo surveillance

Sponsors & Collaborators

Principal Investigators

  • Ugur T. Sener, MD · Mayo Clinic in Rochester

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-12
Primary Completion
2028-08-31
Completion
2028-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07074756 on ClinicalTrials.gov